tradingkey.logo

Ascendis Pharma A/S

ASND
View Detailed Chart

164.150USD

+3.700+2.31%
Close 04/25, 16:00ETQuotes delayed by 15 min
9.95BMarket Cap
LossP/E TTM

Ascendis Pharma A/S

164.150

+3.700+2.31%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.31%

5 Days

-0.55%

1 Month

+6.19%

6 Months

+25.96%

Year to Date

+19.23%

1 Year

+20.79%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 17 analysts
BUY
Current Rating
207.625
Target Price
26.48%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

556
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ascendis Pharma A/S
ASND
17
CRISPR Therapeutics AG
CRSP
29
Regeneron Pharmaceuticals Inc
REGN
28
Intellia Therapeutics Inc
NTLA
28
Moderna Inc
MRNA
27
Exact Sciences Corp
EXAS
27
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(3)
Buy(8)
Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
1.579
Buy
RSI(14)
65.739
Neutral
STOCH(KDJ)(9,3,3)
80.785
Neutral
ATR(14)
10.626
Low Volatility
CCI(14)
87.482
Neutral
Williams %R
7.263
Overbought
TRIX(12,20)
0.719
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
160.604
Buy
MA10
158.663
Buy
MA20
152.569
Buy
MA50
139.545
Buy
MA100
135.224
Buy
MA200
134.731
Buy

News

More news coming soon, stay tuned...

Company

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Company codeASND
CompanyAscendis Pharma A/S
CEOMr. Jan Moller Mikkelsen
Websitehttps://ascendispharma.dk/